Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze FULC stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate FULC investment potential.

What is FULC stock price today?

Get real-time FULC stock price, historical data, and price charts on Financhill. Track FULC performance with our advanced analysis tools.

Is FULC a good investment?

Evaluate FULC investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy FULC stock?

To buy FULC stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of FULC?

View detailed market capitalization data and company valuation metrics for FULC on our comprehensive analysis page.

What is the P/E ratio of FULC?

Use our fundamental analysis tools to view FULC P/E ratio and compare valuation metrics with industry peers.

What are FULC earnings?

View FULC earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Fulcrum Therapeutics, Inc. Stock Predictions

Valuation Up 5,000%. Shares Now $0.85 - Still Early?

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Buy

FULC
Fulcrum Therapeutics, Inc.

Last Price:

$13.09

Seasonality Move:

11.51%

7 Day Trial

ALL ACCESS PASS

$ 7

14K Investors Got In Earlier. You Still Can.

Fulcrum Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Fulcrum Therapeutics, Inc. has on average historically risen by 28.3% based on the past 6 years of stock performance.
Fulcrum Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Fulcrum Therapeutics, Inc. Stock Undervalued?

The current Fulcrum Therapeutics, Inc. [FULC] share price is $13.00. The Score for FULC is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
FULC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Fulcrum Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Fulcrum Therapeutics, Inc. has on average historically risen by 28.3% based on the past 6 years of stock performance.

Fulcrum Therapeutics, Inc. Stock Rating

Buy

Fulcrum Therapeutics, Inc. (FULC) is a Buy

Is Fulcrum Therapeutics, Inc. overpriced?

Fulcrum Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Fulcrum Therapeutics, Inc. Stock Price History

Is FULC stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FULC is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

fulcrumtx.com

52-Week Data

52-Week High:

15.74

52-Week Low:

2.32

Prediction Charts

Market Cap:

703.5M

Price in USD:

13.00

Volume:

1.6M

Beta:

2.40

Technical Analysis

SMA50:

9.75

SMA100:

8.49

SMA200:

6.85

52-Wk Change:

222.58%

Stock Predictions

Is Fulcrum Therapeutics, Inc. stock public?

Yes, Fulcrum Therapeutics, Inc. is a publicly traded company.
What is the Fulcrum Therapeutics, Inc. stock quote today?

The Fulcrum Therapeutics, Inc. stock price is 13.00 USD today.
How to buy Fulcrum Therapeutics, Inc. stock online?

You can buy Fulcrum Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-24	11.73	11.74	12.05	11.40
Nov-25	11.77	11.54	11.99	11.50
Nov-26	11.52	11.32	11.66	11.13
Nov-28	11.33	10.94	11.46	10.50
Dec-1	10.78	9.87	10.94	9.77
Dec-2	9.92	8.95	10.22	8.74
Dec-3	8.92	9.06	9.68	8.73
Dec-4	8.95	8.76	9.29	8.68
Dec-5	8.69	8.90	9.67	8.63
Dec-8	12.96	12.99	15.74	12.74
Dec-9	12.72	14.60	15.29	12.07
Dec-10	14.67	13.80	15.32	13.40
Dec-11	13.55	12.80	13.64	12.56
Dec-12	12.80	13.00	13.19	12.58

Fulcrum Therapeutics, Inc. Earnings

Fulcrum Therapeutics, Inc. Earnings Report: Per Share Fulcrum Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Fulcrum Therapeutics, Inc. Forecast Revenue Growth

Fulcrum Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Fulcrum Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.04 per share, and a decrease next year of $0.03 per share.

* Fulcrum Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.